Palatin Technologies Inc (NYSEMKT:PTN) Shifting Institutional Investors Sentiment

November 10, 2018 - By Peter Kolinski

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) Logo

Sentiment for Palatin Technologies Inc (NYSEMKT:PTN)

Palatin Technologies Inc (NYSEMKT:PTN) institutional sentiment decreased to 2.62 in Q2 2018. Its down -0.56, from 3.18 in 2018Q1. The ratio has worsened, as 55 institutional investors increased or started new holdings, while 21 decreased and sold equity positions in Palatin Technologies Inc. The institutional investors in our partner’s database now own: 43.09 million shares, down from 50.81 million shares in 2018Q1. Also, the number of institutional investors holding Palatin Technologies Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 12 Reduced: 9 Increased: 18 New Position: 37.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company has market cap of $188.49 million. The companyÂ’s principal product is Bremelanotide, an as needed subcutaneous injectable peptide melanocortin receptor agonist, which is in the Phase III clinical studies for the treatment of premenopausal women with hypoactive sexual desire disorder . It has a 7.77 P/E ratio. The Company’s drug development programs also include melanocortin peptide system program, including PL-8177 is a selective melanocortin receptor 1 agonist peptide for inflammatory bowel diseases; and PL-8331, is a preclinical development candidate for treating ocular inflammation.

The stock decreased 3.99% or $0.0388 during the last trading session, reaching $0.9329. About 609,141 shares traded. Palatin Technologies, Inc. (NYSEMKT:PTN) has risen 75.00% since November 10, 2017 and is uptrending. It has outperformed by 59.38% the S&P500.

Analysts await Palatin Technologies, Inc. (NYSEAMERICAN:PTN) to report earnings on November, 12. They expect $-0.03 earnings per share, down 160.00 % or $0.08 from last year’s $0.05 per share. After $0.06 actual earnings per share reported by Palatin Technologies, Inc. for the previous quarter, Wall Street now forecasts -150.00 % negative EPS growth.

Ativo Capital Management Llc holds 0.3% of its portfolio in Palatin Technologies, Inc. for 1.10 million shares. Globeflex Capital L P owns 217,947 shares or 0.04% of their US portfolio. Moreover, Acadian Asset Management Llc has 0.01% invested in the company for 3.25 million shares. The Texas-based Bridgeway Capital Management Inc has invested 0.01% in the stock. Wealthtrust Axiom Llc, a Pennsylvania-based fund reported 21,650 shares.

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: